Document is current
Any future updates will be listed below
-
Authors
He, Yunye https://orcid.org/0000-0001-8581-7826
Koido, Masaru https://orcid.org/0000-0002-0348-0666
Sutoh, Yoichi
Shi, Mingyang
Otsuka-Yamasaki, Yayoi
Munter, Hans Markus https://orcid.org/0000-0002-3165-2840
,
Murakami, Yoishinori
Morisaki, Takayuki
Nagai, Akiko
Murakami, Yoshinori https://orcid.org/0000-0002-2826-4396
Tanikawa, Chizu
Hachiya, Tsuyoshi https://orcid.org/0000-0002-5274-3266
Matsuda, Koichi https://orcid.org/0000-0001-7292-2686
Shimizu, Atsushi
Kamatani, Yoichiro https://orcid.org/0000-0001-8748-5597
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP18km0605001, JP23tm0624002, JP19km0405215, JP223fa627011, JP19km0405215, JP18km0605001, JP23tm0624002, JP19km0405215, JP223fa627011, JP18km0605001, JP23tm0624002)
- License Information
-
More Information
Article History
Received: 1 November 2022
Accepted: 12 October 2023
First Online: 30 November 2023
Competing interests
: Y.K. holds stock in StaGen Co. Ltd. T.H. is a board member of Genome Analytics Japan Inc. The other authors declare no competing interests.
